<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="613">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 01, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01983163</url>
  </required_header>
  <id_info>
    <org_study_id>9968480606</org_study_id>
    <nct_id>NCT01983163</nct_id>
  </id_info>
  <brief_title>Efficacy of Modified Atkins Diet Versus Ketogenic Diet in Children With Refractory Epilepsy Aged 1 Year to 18 Years: A Randomized Controlled Trial</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, New Delhi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, New Delhi</source>
  <oversight_info>
    <authority>India: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In children aged 1yr -18 years with refractory epilepsy Modified Atkins diet as add on to
      ongoing AED therapy would not be inferior compared to ketogenic diet ** in terms of seizure
      reduction from baseline seizure frequency at 6 months
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective:

      To compare the efficacy of Modified Atkins diet compared to Ketogenic diet * in children
      aged 1 year to 18 years of age with refractory epilepsy on anti epileptic drugs at 6 months
      of diet intake in terms of percentage of seizure reduction from base line.

      Secondary objective:

      Proportion of patients who achieve &gt; 50% seizure reduction from baseline after 6 months in
      both groups To evaluate the nature of adverse events in both the groups
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Percentage of seizure reduction at 6 months ( sz frequency / wk average of 4 wks) from base line</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To develop an optimal dietary therapy for management of refractory epilepsy in children and adolescents</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ketogenic Diet, Modified Atkin's Diet, Refractory Epilepsy</condition>
  <arm_group>
    <arm_group_label>ketogenic diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ketogenic diet (2.5 to 4:1)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Modifid Atkin's diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Modified Atkin's Diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ketogenic diet (2.5 to 4:1)</intervention_name>
    <arm_group_label>ketogenic diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Modified Atkin's diet</intervention_name>
    <arm_group_label>Modifid Atkin's diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 1-18 years with refractory epilepsy*

          -  Willing to come for regular follow up

          -  No motivational or psychosocial issues in the family which would preclude compliance
             with the diet

        Exclusion Criteria

          -  Surgically remediable cause for refractory epilepsy

          -  Suspected mitochondrial disorder or diagnosed with a disorder in which high fat diet
             is contraindicated

          -  Previously received ketogenic diet or modified Atkins diet

          -  Chronic systemic disease like chronic kidney disease, chronic liver disease, heart
             disease (congenital and acquired) and chronic respiratory illness
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sheffali Gulati, MD Pediatrics</last_name>
    <phone>01126594679</phone>
    <email>sheffaligulati@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheffali Gulati, MD, Pediatrics</last_name>
      <phone>01126594679</phone>
      <email>sheffaligulati@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 7, 2013</lastchanged_date>
  <firstreceived_date>November 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>All India Institute of Medical Sciences, New Delhi</investigator_affiliation>
    <investigator_full_name>Sheffali Gulati</investigator_full_name>
    <investigator_title>Addl. Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
